Philips Releases Latest Data Reinforcing Safety Profile of Stellarex Low-Dose Drug-Coated Balloon - Cath Lab Digest

Philips Releases Latest Data Reinforcing Safety Profile of Stellarex Low-Dose Drug-Coated Balloon  Cath Lab Digest

Amsterdam, the Netherlands (Jan 28, 2019) – Royal Philips announced the release of the latest pooled analysis of patient-level data of over 2,300 patients ...



Comments

Post a Comment

Popular posts from this blog

Orchestra BioMed™ Announces FDA Breakthrough Device Designation for Virtue® Sirolimus-Eluting Balloon for Treatment of Below-the-Knee Peripheral Artery Disease - Vascular Disease Management

Orchestra BioMed™ Announces FDA Breakthrough Device Designation for Virtue® Sirolimus-Eluting Balloon for Treatment of Below-the-Knee Peripheral Artery Disease    Vascular Disease Management First and only non-coated sirolimus-eluting angioplasty balloon system to receive Breakthrough Device designation for below-the-knee disease; Follows ...
Read more